These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 1310075)
1. Novel activin receptors: distinct genes and alternative mRNA splicing generate a repertoire of serine/threonine kinase receptors. Attisano L; Wrana JL; Cheifetz S; Massagué J Cell; 1992 Jan; 68(1):97-108. PubMed ID: 1310075 [TBL] [Abstract][Full Text] [Related]
2. Expression cloning of an activin receptor, a predicted transmembrane serine kinase. Mathews LS; Vale WW Cell; 1991 Jun; 65(6):973-82. PubMed ID: 1646080 [TBL] [Abstract][Full Text] [Related]
3. Bovine activin receptor type IIB messenger ribonucleic acid displays alternative splicing involving a sequence homologous to Src-homology 3 domain binding sites. Ethier JF; Lussier JG; Silversides DW Endocrinology; 1997 Jun; 138(6):2425-34. PubMed ID: 9165032 [TBL] [Abstract][Full Text] [Related]
4. Molecular cloning and characterization of a novel rat activin receptor. Legerski R; Zhou X; Dresback J; Eberspaecher H; McKinney S; Segarini P; de Crombrugghe B Biochem Biophys Res Commun; 1992 Mar; 183(2):672-9. PubMed ID: 1312838 [TBL] [Abstract][Full Text] [Related]
5. Molecular cloning and binding properties of the human type II activin receptor. Donaldson CJ; Mathews LS; Vale WW Biochem Biophys Res Commun; 1992 Apr; 184(1):310-6. PubMed ID: 1314589 [TBL] [Abstract][Full Text] [Related]
6. Expression of activin receptor II and IIB mRNA isoforms in mouse reproductive organs and oocytes. Wu TC; Jih MH; Wang L; Wan YJ Mol Reprod Dev; 1994 May; 38(1):9-15. PubMed ID: 8049070 [TBL] [Abstract][Full Text] [Related]
7. Molecular characterization of a type I serine-threonine kinase receptor for TGF-beta and activin in the rat pituitary tumor cell line GH3. Takumi T; Moustakas A; Lin HY; Lodish HF Exp Cell Res; 1995 Jan; 216(1):208-14. PubMed ID: 7813622 [TBL] [Abstract][Full Text] [Related]
8. Tumor-specific expression and alternate splicing of messenger ribonucleic acid encoding activin/transforming growth factor-beta receptors in human pituitary adenomas. Alexander JM; Bikkal HA; Zervas NT; Laws ER; Klibanski A J Clin Endocrinol Metab; 1996 Feb; 81(2):783-90. PubMed ID: 8636304 [TBL] [Abstract][Full Text] [Related]
9. Identification of human activin and TGF beta type I receptors that form heteromeric kinase complexes with type II receptors. Attisano L; Cárcamo J; Ventura F; Weis FM; Massagué J; Wrana JL Cell; 1993 Nov; 75(4):671-80. PubMed ID: 8242742 [TBL] [Abstract][Full Text] [Related]
10. Inhibin antagonizes inhibition of liver cell growth by activin by a dominant-negative mechanism. Xu J; McKeehan K; Matsuzaki K; McKeehan WL J Biol Chem; 1995 Mar; 270(11):6308-13. PubMed ID: 7890768 [TBL] [Abstract][Full Text] [Related]
11. Formation and activation by phosphorylation of activin receptor complexes. Willis SA; Zimmerman CM; Li LI; Mathews LS Mol Endocrinol; 1996 Apr; 10(4):367-79. PubMed ID: 8721982 [TBL] [Abstract][Full Text] [Related]
12. Cloning of a second type of activin receptor and functional characterization in Xenopus embryos. Mathews LS; Vale WW; Kintner CR Science; 1992 Mar; 255(5052):1702-5. PubMed ID: 1313188 [TBL] [Abstract][Full Text] [Related]
13. Characterization of in vivo phosphorylation of activin type II receptor. Ichijo H; Yamashita H; ten Dijke P; Eto Y; Heldin CH; Miyazono K Biochem Biophys Res Commun; 1993 Aug; 194(3):1508-14. PubMed ID: 8394710 [TBL] [Abstract][Full Text] [Related]
14. Developmental expression of four novel serine/threonine kinase receptors homologous to the activin/transforming growth factor-beta type II receptor family. He WW; Gustafson ML; Hirobe S; Donahoe PK Dev Dyn; 1993 Feb; 196(2):133-42. PubMed ID: 8395914 [TBL] [Abstract][Full Text] [Related]
15. A widely expressed transmembrane serine/threonine kinase that does not bind activin, inhibin, transforming growth factor beta, or bone morphogenic factor. Matsuzaki K; Xu J; Wang F; McKeehan WL; Krummen L; Kan M J Biol Chem; 1993 Jun; 268(17):12719-23. PubMed ID: 8389764 [TBL] [Abstract][Full Text] [Related]
16. Expression of type II activin receptor genes during differentiation of human K562 cells and cDNA cloning of the human type IIB activin receptor. Hildén K; Tuuri T; Erämaa M; Ritvos O Blood; 1994 Apr; 83(8):2163-70. PubMed ID: 8161782 [TBL] [Abstract][Full Text] [Related]
18. Cloning and characterization of a transmembrane serine kinase that acts as an activin type I receptor. Tsuchida K; Mathews LS; Vale WW Proc Natl Acad Sci U S A; 1993 Dec; 90(23):11242-6. PubMed ID: 8248234 [TBL] [Abstract][Full Text] [Related]
19. Activin and its receptors during gastrulation and the later phases of mesoderm development in the chick embryo. Stern CD; Yu RT; Kakizuka A; Kintner CR; Mathews LS; Vale WW; Evans RM; Umesono K Dev Biol; 1995 Nov; 172(1):192-205. PubMed ID: 7589799 [TBL] [Abstract][Full Text] [Related]
20. Isolation and characterization of activin receptor from mouse embryonal carcinoma cells. Identification of its serine/threonine/tyrosine protein kinase activity. Nakamura T; Sugino K; Kurosawa N; Sawai M; Takio K; Eto Y; Iwashita S; Muramatsu M; Titani K; Sugino H J Biol Chem; 1992 Sep; 267(26):18924-8. PubMed ID: 1326537 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]